- Home
- CRIS vs PIII Comparison
CRIS vs PIII Comparison
Compare CRIS & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- PIII
- Stock Information
- Founded
- CRIS 2000
- PIII 2015
- Country
- CRIS United States
- PIII United States
- Employees
- CRIS N/A
- PIII N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- PIII Medical/Nursing Services
- Sector
- CRIS Health Care
- PIII Health Care
- Exchange
- CRIS Nasdaq
- PIII Nasdaq
- Market Cap
- CRIS 22.9M
- PIII 28.6M
- IPO Year
- CRIS 2000
- PIII N/A
- Fundamental
- Price
- CRIS $1.70
- PIII $8.63
- Analyst Decision
- CRIS Strong Buy
- PIII Strong Buy
- Analyst Count
- CRIS 2
- PIII 3
- Target Price
- CRIS $16.50
- PIII $17.50
- AVG Volume (30 Days)
- CRIS 75.9K
- PIII 6.9K
- Earning Date
- CRIS 11-13-2025
- PIII 11-11-2025
- Dividend Yield
- CRIS N/A
- PIII N/A
- EPS Growth
- CRIS N/A
- PIII N/A
- EPS
- CRIS N/A
- PIII N/A
- Revenue
- CRIS $11,405,000.00
- PIII $1,461,823,000.00
- Revenue This Year
- CRIS $1.41
- PIII N/A
- Revenue Next Year
- CRIS $7.46
- PIII $9.46
- P/E Ratio
- CRIS N/A
- PIII N/A
- Revenue Growth
- CRIS 12.24
- PIII 4.20
- 52 Week Low
- CRIS $1.02
- PIII $5.80
- 52 Week High
- CRIS $6.44
- PIII $26.99
- Technical
- Relative Strength Index (RSI)
- CRIS 47.75
- PIII 66.82
- Support Level
- CRIS $1.63
- PIII $8.46
- Resistance Level
- CRIS $1.95
- PIII $8.90
- Average True Range (ATR)
- CRIS 0.14
- PIII 0.32
- MACD
- CRIS 0.02
- PIII 0.01
- Stochastic Oscillator
- CRIS 26.47
- PIII 80.29
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.